Skip to content

Research at St Andrews

Investigation of the cyclic oligoadenylate signaling pathway of type III CRISPR systems

Research output: Chapter in Book/Report/Conference proceedingChapter

Author(s)

Christophe Rouillon, Januka S. Athukoralage, Shirley Graham, Sabine Grüschow, Malcolm F. White

School/Research organisations

Abstract

Type III CRISPR effector complexes utilize a bound CRISPR RNA (crRNA) to detect the presence of RNA from invading mobile genetic elements in the cell. This RNA binding results in the activation of two enzymatic domains of the Cas10 subunit—the HD nuclease domain, which degrades DNA, and PALM/cyclase domain. The latter synthesizes cyclic oligoadenylate (cOA) molecules by polymerizing ATP, and cOA acts as a second messenger in the cell, switching on the antiviral response by activating host ribonucleases and other proteins. In this chapter, we focus on the methods required to study the biochemistry of this recently discovered cOA signaling pathway. We cover protein expression and purification, synthesis of cOA and its linear analogues, kinetic analysis of cOA synthesis and cOA-stimulated ribonuclease activity, and small molecule detection and identification with thin-layer chromatography and mass spectrometry. The methods described are based on our recent studies of the type III CRISPR system in Sulfolobus solfataricus, but are widely applicable to other type III systems.

Close

Details

Original languageEnglish
Title of host publicationMethods in Enzymology
EditorsScott Bailey
PublisherAcademic Press Inc.
Pages191-218
Number of pages28
ISBN (Print)9780128167601
DOIs
Publication statusPublished - 1 Jan 2019

Publication series

NameMethods in Enzymology
Volume616
ISSN (Print)0076-6879
ISSN (Electronic)1557-7988

    Research areas

  • CARF, CRISPR type III, Csm6, Csx1, Cyclic oligoadenylate, HEPN, MazEF, Ribonuclease, Ring nuclease

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Cyclic oligoadenylate signalling mediates Mycobacterium tuberculosis CRISPR defence

    Grüschow, S., Athukoralage, J. S., Graham, S., Hoogeboom, T. & White, M. F., 26 Sep 2019, In : Nucleic Acids Research. 47, 17, p. 9259-9270 12 p.

    Research output: Contribution to journalArticle

  2. A type III CRISPR ancillary ribonuclease degrades its cyclic oligoadenylate activator

    Athukoralage, J. S., Graham, S., Grüschow, S., Rouillon, C. & White, M. F., 12 Jul 2019, In : Journal of Molecular Biology. 431, 15, p. 2894-2899

    Research output: Contribution to journalArticle

  3. Ring nucleases deactivate Type III CRISPR ribonucleases by degrading cyclic oligoadenylate

    Athukoralage, J. S., Rouillon, C., Graham, S., Grüschow, S. & White, M. F., 11 Oct 2018, In : Nature. 562, 7726, p. 277-280 16 p.

    Research output: Contribution to journalArticle

  4. Control of cyclic oligoadenylate synthesis in a type III CRISPR system

    Rouillon, C., Athukoralage, J. S., Graham, S., Grüschow, S. & White, M. F., 19 Jul 2018, In : eLife. 7, 22 p., e36734.

    Research output: Contribution to journalArticle

  5. Asymmetric base pair opening drives helicase unwinding dynamics

    Colizzi, F., Perez-Gonzalez, C., Fritzen, R., Levy, Y., White, M. F., Penedo-Esteiro, J. C. & Bussi, G., 5 Nov 2019, In : Proceedings of the National Academy of Sciences of the United States of America. 116, 45, p. 22471-22477 7 p.

    Research output: Contribution to journalArticle

ID: 258109138

Top